Patent Application
20220087842
The present application claims priority to Korean Patent Application No. 10-2020-0124140, filed Sep. 24, 2020, the entire contents of which is incorporated herein for all purposes by this reference.
The present disclosure relates to a biliary stent unit, particularly, to a biliary stent unit which prevents a stent from separating from a diseased part of the biliary tract due to shaking of a human body or an external force by a pulling thread fixed outside the human body, that is, to the skin, and which reduces stimulus inside the human body due to shaking of the human body or an external force using a flexible soft tube protecting the pulling thread.
In general, stents have been used to expand the inside a lumen narrowed by a diseased part due to stricture or occlusion inside a human body so that the lumen is not narrowed back by the diseased part.
In relation to this subject, a biliary stent unit having a cylindrical body in which a space is formed by twisting or crossing in a zigzag pattern one or more pieces of shape memory ally wires together and several bending ends are circumferentially formed at both ends thereof has been disclosed in Patent Document 1. According to this configuration, a loop formed by tying both ends of a pulling thread twisted in a circular band type in a zigzag pattern in the space of the cylindrical body is placed to be exposed lengthily outside a human body so that the stent does not slide in the biliary tract in surgery, and when the loop is pulled at the outside of the human body to remove the stent, the stent is taken out while the edge of the end of the stent closes toward the center, whereby the stent can be easily removed. Further, a port chamber is provided such that the loop of the pulling thread passes through a tube-shaped catheter, which is inserted in a portion of a human body in which the stent is inserted, and is then tied and fixed in a port body extending from an end of the port catheter and configured to be positioned outside the human body. Accordingly, the loop is positioned inside the port catheter and is prevented from being contaminated.
However, according to Patent Document 1, since the port catheter is made of a hard material and is not flexible, stimulus inside a human body due to shaking of the body or an external force may be increased.
That is, the patient who has the biliary stent unit may feel pain.
(Patent Document 1) Korean Patent No. 10-1065365 (registered on Sep. 8, 2011)
Accordingly, an objective of the present disclosure is to provide a biliary stent unit which prevents a stent from separating from a diseased part of the biliary tract due to shaking of a human body or an external force by a pulling thread fixed outside the human body, that is, to the skin, and which reduces stimulus inside the human body due to shaking of the human body or an external force using a flexible soft tube protecting the pulling thread.
In order to achieve the objectives of the present disclosure, a biliary stent unit includes: a stent that has a cylindrical body having several spaces formed by twisting or crossing wires, which are made of a superelastic shape memory alloy, in a hollow cylindrical net shape, and having several bending portions formed around an edge of both ends thereof, that includes a pulling cord, which is tied to the space of the several bending portions at a first end of the cylindrical body, has two parts having different lengths and protruding from the first end of the cylindrical body, has a knot formed by tying the two parts having different lengths, and of which the longer part protrudes outside a human body, and that is applied to a diseased part generated due to stricture or occlusion in the biliary tract of the human body; a pulling rod that has a hook for fixing and releasing the pulling thread protruding outside the human body; a soft tube in which the pulling thread, which is fixed to the hook pulled out of the human body when the pulling rod is pulled, is inserted, that is guided close to the stent in the human body by the pulling thread, and that has a male thread portion at a portion exposed outside the human body; a cap that has a female thread portion, which is fastened to the male thread portion, on an inner surface thereof, that has a through-hole on an outer surface thereof, through which the pulling thread lengthily pulled out of the human body when the puling rod is pulled and then fixed to the hook, passes, and that presses and fixes the pulling thread, which passes through the through-hole when the female thread portion and the male thread portion are fastened and is then wound on an outer surface of the applied flexible tube, on the skin of the human body; and a fixing member that covers and fixes the cap, which fixes the pulling thread on the skin of the human body, on the skin of the human body.
The present disclosure has an effect that the pulling thread is fixed outside a human body, that is, on the skin of the human body by the cap coupled to the soft tube, and the cap is fixed outside the human body, that is, on the skin of the human body by the fixing member.
That is, there is an effect that since the pulling thread is fixed on the skin of the human body, the stent is prevented from separating from a diseased part of the biliary tract due to shaking of the human body and an external force.
The present disclosure has an effect that stimulus that is generated in a human body due to shaking of the human body and an external force is reduced by the soft tube having flexibility and protecting the pulling thread.
That is, there is an effect that a pain is prevented by the soft tube.
The present disclosure has an effect that since the cap is covered with the fixing member, the pulling thread is not exposed outside.
That is, there is an effect that contamination of the pulling thread due to exposure to the outside is prevented.
The present disclosure has an effect that the stent is guided through the soft tube and removed out of a human body when the pulling thread is pulled after treatment for 2 to 16 weeks.
That is, there is an effect that the stent is easily removed out of a human body by the soft tube forming a passage, that is, a path in the human body.
There is an effect that the soft tube prevents the stent from being caught on organs inside a human body.
The present disclosure has an effect that it is possible to remove the stent by pulling only one part rather than both parts of the pulling thread using the knot after treatment for 2 to 16 weeks.
The present disclosure has an effect that since the pulling thread is fixed to the hook of the pulling rod, the pulling thread is easily lengthily pulled out of a human body and is easily inserted into the soft tube.
The present disclosure has an effect that the soft tube prevents stricture of the pulling thread and organs in a human body during treatment for 2 to 16 weeks.
The present disclosure has an effect that the gap between the stent and the knot prevents the compressed stent from being caught on the knot while the stent expands.
That is, there is an effect of preventing the biliary tract narrowed at a diseased part from failing to expand due to abnormal expansion of the stent.
The present disclosure has an effect that since there is a gap of 3 mm˜10 mm, the phenomenon that the compressed stent is caught on the knot when it expands and the stent is caught when it is mounted on the stent delivery device.
That is, there is an effect that the stent is easily applied to a diseased part and is easily mounted on the stent delivery device.
Further, there is an effect that since the first end of the cylindrical body is closed well by the gap of 3 mm 10 mm when the pulling thread is pulled to remove the stent, the stent is not caught on the inlet of the soft tube.
That is, there is an effect that the stent is easily removed after treatment for 2 to 16 weeks.
The present disclosure has an effect that since contamination due to bacteria at the outside of a human body is prevented by the antibacterial agent coated on the pulling thread, inflammation of the skin of a human body due to contamination is prevented.
The present disclosure has an effect that since the bile cannot permeate into the pulling thread made of nylon, the bile is prevented from leaking out of the human body when the stent is removed.
The present disclosure has an effect that since the pulling thread is a single piece of thread, there is no gap in which the bile permeates.
Further, there is an effect that the bile is prevented from being discharged from the human body when the stent is removed.
The present disclosure has an effect that since both parts of the pulling thread are fastened to the loop and the knot is not untied when the pulling thread is pulled, the pulling thread is not separated from the stent when the pulling thread is pulled.
That is, there is an effect that the stent is prevented from remaining without being removed in the biliary tract of a human body after treatment for 2 to 16 weeks.
The present disclosure has an effect that the membrane made of silicone or PTFE (Polytetrafluoroethylene) helps the bile move and prevents the bile from being stuck in the spaces.
Further, there is an effect that the bile is prevented from being discharged from the human body when the stent is removed.
The above and other objectives, features and other advantages of the present invention will be more clearly understood from the following detailed description when taken in conjunction with the accompanying drawings, in which:
Hereafter, various embodiments of the present invention are described in detail with reference to the accompanying drawings.
As shown in
That is, the biliary stent unit 1000 is implanted a diseased part 3 that is generated at the biliary tract 2 of a human body 1 after hepatectomy and liver transplant due to hepatoma and cirrhosis, or a diseased part 3 that is generated at the biliary tract 2 of the human body 1 due to bile duct cancer.
The biliary stent unit 1000 is maintained at the operated position for 2 to 16 weeks until the diseased part 3 is completely cured.
As shown in
The stent 100 includes a cylindrical body 110 that has several spaces 112 formed by twisting or crossing one or more wires 111, which are made of a superelastic shape memory alloy, in a hollow cylindrical net shape, and that has several bending portions 113 formed around the edge of both ends thereof.
The cylindrical body 100 of the stent 100 is compressed in a stent delivery device, and is separated and expanded from the stent delivery device when it is applied to a diseased part by the stent delivery device.
The stent 100 includes a pulling thread 120 that is fastened to the space 112 of the several bending portions 113 at a first end of the cylindrical body 110, has two parts having different lengths and protruding from the first end of the cylindrical body 110, has a knot 121 formed by tying the two parts having different lengths, and of which the longer part protrudes outside the human body 1.
The cylindrical body 110 of the stent 100 is mounted in the stent delivery device such that the pulling thread 120 is positioned in the opposite direction to the direction that passes through the skin, liver 4, and biliary tract 2 of the human body 1.
The pulling thread 120 is coated with an antibacterial agent, so an antibacterial agent layer 120a is formed on the outer surface thereof.
The pulling thread 120 is made of nylon.
The pulling thread 120 is not formed by twisting several pieces of strings and is a single string.
There is a gap 122 between the knot 121 and the first end of the cylindrical body 110 at which the pulling thread 120 is fastened to the space 112 of the several being portion 113.
When the gap 122 is 3 mm or less, the first end of the cylindrical body 110 and the knot 121 are too close to each other, so the compressed stent 110 may not normally expand by being blocked by the knot 121 while expanding for surgery.
When the gap 122 is 10 mm or more, the first end of the cylindrical body 110 and the knot 121 are too far from each other, so the first end of the cylindrical body 110 may not normally close when the pulling thread 120 is pulled to remove the stent 100.
Further, when the gap 122 is 10 mm or more, the first end of the cylindrical body 110 and the knot 121 are too far from each other, so the knot 121 is frequently stuck in a stent delivery device when the stent 100 is mounted in the stent delivery device, and accordingly, it is difficult to mount the stent 100.
Accordingly, the gap 122 is set as 3 mm˜10 mm.
As shown in
That is, the knot 121 is formed not to be untied when the pulling thread 120 is pulled.
The first part 121a of the pulling thread 120 protrudes outside the human body 1.
The biliary stent unit 1000 includes a pulling rod 200 having a hook 210 for fixing and releasing the pulling thread 120 protruding outside the human body 1.
The pulling rod is formed like a long iron core.
The pulling thread 120 may be wound on the hook 210 or may have a loop in which the hook 210 is inserted to be hooked and fixed to the hook 210.
The biliary stent unit 1000 includes a soft tube 300 in which the pulling thread 120, which is fixed to the hook 210 and is lengthily pulled out of the human body 1 when the pulling rod 200 is pulled, is inserted, that is guided close to the stent 100 in the human body 1 by the pulling thread 120, and that has a male thread portion 310 at a portion exposed outside the human body 1.
The soft tube 300 is formed similar to a duct and is made of silicone or rubber.
The biliary stent unit 1000 includes a cap 400 that has a female thread portion 410, which is fastened to the male thread portion 310, on the inner surface thereof, that has a through-hole 410 on the outer surface thereof, through which the pulling thread 410 lengthily pulled out of the human body 1 when the puling rod 200 is pulled and then released from the hook 210m passes, and that presses and fixes the pulling thread 120, which passes through the through-hole 420 when the female thread portion 410 and the male thread portion 310 are fastened and is then wound on the outer surface of the implanted soft tube 300, on the skin of the human body 1.
The cap 400 is made of silicone or rubber.
The biliary stent unit 1000 includes a fixing member 500 that covers and fixes the cap 400, which fixes the pulling thread 120 on the skin of the human body 1, on the skin of the human body 1.
The fixing member 500 includes a gauze or a bandage covering the cap 400 fixing the pulling thread 120 on the skin of the human body 1, an adhesive or a tape attaching the gauze or the bandage to the skin of the human body 1, etc.
As shown in
The spaces 112 are covered with the membrane 114.
The pulling thread 120 is fastened to the space of the bending portions 113 and the membrane 114.
The operation of the biliary stent unit 1000 having the above configuration of the present disclosure is described hereafter.
As shown in
In detail, an operator cuts the skin of the human body 1, secures a visual field using an endoscope, inserts a stent delivery device through the skin, the liver 4, and the biliary tract 2 of the human body 1, checks the position of a diseased part 3 using the endoscope, and applies the stent to the diseased part 3 using the stent delivery device, thereby expanding the diseased part 3.
Since there is a gap 122 of 3 mm˜10 mm between the knot 121 and the first end of the cylindrical body 110 of the stent 100, the compressed stent 100 easily expands in the diseased part 3 without being caught on the knot 121.
The diseased part 3 is inserted in the spaces 112 of the stent 100.
When the stent delivery device is removed from the human body 1, the pulling thread 120 is protruded out of the human body 1 by the stent delivery device.
That is, the longer part 121a of the pulling thread 120 which protrudes from the first end of the cylindrical body 110 protrudes out of the human body 1.
Next, the pulling thread 120 protruding out of the human body 1 is fixed to the hook 210 of the pulling rod 200 and then the pulling rod 200 is pulled, whereby the pulling thread 120 fixed to the hook 210 is lengthily pulled out of the human body 1.
Further, the pulling thread 120 fixed to the hook 210 is inserted into the soft tube 300.
The pulling thread 120 is released from the hook 210 pulled out of the soft tube 300 and then the soft tube 300 is moved along the pulling thread 120 and inserted into the skin, the liver 4, and the biliary tract 2 of the human body 1 pierced by the stent delivery device.
That is, the soft tube 300 is guided by the pulling thread 120 and positioned in the skin, liver 4, and biliary tract 2 of the human body 1 pierced by the stent delivery device.
The soft tube 300 is left close to the stent 100 in the human body 1.
The soft tube 300 provides a passage, that is, a path for easily removing the stent 100 after treatment for 2 to 16 weeks in the human body 1.
The pulling thread 120 released from the hook 210 is inserted through the through-hole 420 of the cap 400 and then wound on the outer surface on the portion of the soft tube 300 exposed outside the human body 1.
Next, the male thread portion 310 of the soft tube 300 exposed outside the human body 1 and the female thread portion 410 of the cap 400 are fastened to each other, whereby the pulling thread 120 wound on the outer surface of the soft tube 300 is pressed by the cap 400.
Accordingly, the pulling thread 120 is pressed fixed on the skin of the human body 1 by the cap 400.
The cap 400 fixing the pulling thread 120 on the skin of the human body 1 is covered with the fixing member 500, whereby the cap 400 is fixed on the skin of the human body 1.
Accordingly, the pulling thread 120 is fixed at the outside of the human body 1, that is, fixed on the skin, and the stent 100 is fixed in the human body 1, that is, in the diseased part 3 of the biliary tract.
Therefore, the stent 100 of the biliary stent unit 1000 according to an embodiment of the present disclosure is prevented from separating from the diseased part 3 due to shaking of the human body or an external force.
The soft tube 300 is deformed when the human body 1 is shaken and an external force is applied, and is returned to the initial state by elasticity when shaking of the human body 1 and the external force is removed.
Since the antibacterial agent layer 120a is formed on the outer surface of the pulling thread 120, contamination of the pulling thread 120 due to bacteria is prevented even though the pulling thread 120 is exposed outside the human body for a long period of time.
Since the pulling thread 120 is made of nylon, the bile flowing through the biliary tract 2 is prevented from permeating into the pulling thread 120.
When the diseased part 3 is completely cured for 2 to 16 weeks, the biliary stent unit 1000 is removed.
In detail, the fixing member 500 is removed from the cap 400 on the skin of the human body 1, and then the female thread portion 410 of the cap 400 and the male thread portion 310 of the soft tube 300 are separated.
In this process, the pressure applied to the pulling thread 120 by the cap 400 is removed.
Thereafter, the pulling thread 120 is pulled.
As the pulling thread 120 is pulled, the cylindrical body 110 is inserted into the soft tube while the first end to which the pulling thread 120 is fastened is closed.
The first end of the cylindrical body 110 to which the pulling thread 120 is fastened is closed well by the gap 122 of 3 mm˜10 mm, so the stent 100 is easily inserted into the soft tube 300 when the pulling thread 120 is pulled.
Accordingly, the stent 100 is taken out of the biliary tract 2 of the human body 1.
Since both parts 121a and 121b of the pulling thread 120 are fastened to the loop 121c, the knot 121 is not untied when the pulling thread 120 is pulled.
When the pulling thread 120 is pulled, the stent 100 is guided by the soft tube 300 and taken out of the soft tube 300.
That is, the stent 100 is easily guided through the soft tube 300 forming a passage, that is, a path in the human body 1 and taken out of the soft tube 300, thereby being removed.
Then, the soft tube 300 is pulled out of the human body 1.
As shown in
The diseased part 3 is not inserted in the spaces 112 covered by the membrane 114.
Although the present disclosure was described above with reference to specific embodiments, the present disclosure is not limited to the embodiments and may be changed and modified in various ways by those skilled in the art without departing from the scope of the present disclosure.
| Number | Date | Country | Kind |
|---|---|---|---|
| 10-2020-0124140 | Sep 2020 | KR | national |
